PMID: 2884125Feb 1, 1987

Topical timolol, at conventional, unilateral doses causes bilateral ocular beta-blockade in rabbits

Experimental Eye Research
D F WoodwardJ Chen

Abstract

The studies described herein reveal that unilateral 0.3% and 1% doses of timolol produce marked beta-adrenoceptor blockade in treated and in contralateral eyes which did not receive timolol. This indicates that unilateral, conventional topical doses of timolol administered to rabbits cause bilateral ocular beta-adrenoceptor blockade. In addition, 0.1% and 1% doses of timolol applied to one eye resulted in blockade of cardiovascular beta-adrenoceptors. Thus, the most likely explanation for bilateral ocular beta-blockade would be systemic absorption of timolol from the treated eye and redistribution to the fellow eye. Since contralateral eyes would not provide an adequate control in circumstances where a large dose of timolol is administered unilaterally, caution must be exercised in interpreting data obtained in laboratory animals with doses of timolol similar to those employed clinically. A 0.01% dose of timolol appears adequate to achieve marked, unilateral ocular beta-adrenoceptor blockade in rabbits.

References

Mar 5, 1979·Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology·L BonomiF Massa
May 1, 1979·Survey of Ophthalmology·A H Neufeld
May 1, 1977·The British Journal of Ophthalmology·K Wettrell, M Pandolfi
Nov 1, 1978·Archives of Ophthalmology·R L Coakes, R F Brubaker
Jan 1, 1979·Ophthalmology·E D BatchelorA J Wood
May 1, 1979·Survey of Ophthalmology·L L LinI Katz
Jan 1, 1979·Ophthalmology·T J Zimmerman, P Canale
Jan 1, 1979·Ophthalmology·R P WilsonG L Spaeth
Aug 1, 1978·Experimental Eye Research·M E YablonskiB Becker
Jun 1, 1975·The British Journal of Ophthalmology·I Bonomi, P Steindler
Sep 1, 1974·Experimental Eye Research·M E Langham, E Diggs
Jan 1, 1970·Archives of Ophthalmology·R A Ross, S M Drance
Apr 1, 1967·The British Journal of Ophthalmology·C I PhillipsD J Rowlands
May 1, 1981·British Journal of Pharmacology·J A Nathanson
Oct 1, 1984·Archives of Ophthalmology·W J DoyleR H Meeks
Jan 1, 1982·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·E Stenkula, K Wettrell
Oct 15, 1982·European Journal of Pharmacology·V S MurthyD H Schmidt
Jan 1, 1982·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·P J AiraksinenA Klemetti
Nov 1, 1955·American Journal of Ophthalmology·R WEEKERSJ GUSTIN

Citations

Jan 1, 1989·Pharmacology & Therapeutics·M F Sugrue
Jan 1, 1989·Journal of Ocular Pharmacology·P P Ellis, M A Riegel
Jan 8, 1999·Experimental Eye Research·J W Kiel, P Patel

Related Concepts

Administration, Topical
Adrenergic beta-Antagonists
Diastolic Blood Pressure
Dose-Response Relationship, Drug
Eye
Pulse Rate
Physiologic Intraocular Pressure
Novodrin
Timoptol

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.